FR2426693A1 - ANTIBIOTIC OF THE CEPHALOSPORIN TYPE AND ITS PREPARATION PROCESS - Google Patents

ANTIBIOTIC OF THE CEPHALOSPORIN TYPE AND ITS PREPARATION PROCESS

Info

Publication number
FR2426693A1
FR2426693A1 FR7913527A FR7913527A FR2426693A1 FR 2426693 A1 FR2426693 A1 FR 2426693A1 FR 7913527 A FR7913527 A FR 7913527A FR 7913527 A FR7913527 A FR 7913527A FR 2426693 A1 FR2426693 A1 FR 2426693A1
Authority
FR
France
Prior art keywords
antibiotic
preparation process
cephalosporin type
cephalosporin
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7913527A
Other languages
French (fr)
Other versions
FR2426693B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FR2426693A1 publication Critical patent/FR2426693A1/en
Application granted granted Critical
Publication of FR2426693B1 publication Critical patent/FR2426693B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des céphalosporines. L'invention a plus particulièrement pour objet un composé de la formule générale I :The invention relates to cephalosporins. A more particular subject of the invention is a compound of general formula I:

FR7913527A 1978-05-26 1979-05-28 ANTIBIOTIC OF THE CEPHALOSPORIN TYPE AND ITS PREPARATION PROCESS Granted FR2426693A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB22909/78A GB1604722A (en) 1978-05-26 1978-05-26 7-(2-(2-amino-4-thiozolyl)-2-oxymino-acetamido)-cephem derivatives

Publications (2)

Publication Number Publication Date
FR2426693A1 true FR2426693A1 (en) 1979-12-21
FR2426693B1 FR2426693B1 (en) 1983-02-04

Family

ID=10187026

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7913527A Granted FR2426693A1 (en) 1978-05-26 1979-05-28 ANTIBIOTIC OF THE CEPHALOSPORIN TYPE AND ITS PREPARATION PROCESS

Country Status (9)

Country Link
JP (2) JPS54154789A (en)
BE (2) BE876541A (en)
CH (1) CH646704A5 (en)
DE (1) DE2921288A1 (en)
FR (1) FR2426693A1 (en)
GB (1) GB1604722A (en)
IT (1) IT1116196B (en)
NL (1) NL7904127A (en)
ZA (1) ZA792584B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE878514A (en) * 1978-09-04 1980-02-29 Fujisawa Pharmaceutical Co PROCESS FOR THE PREPARATION OF 3-CEPHEM-4-CARBOXYLIC ACID COMPOUNDS WITH DISUBSTITUTION IN POSITIONS 3 AND 7, NOVEL PRODUCTS THUS OBTAINED AND THEIR USE FOR THEIR ANTIBACTERIAL ACTIVITY
DE3787030T2 (en) * 1986-04-14 1994-04-07 Banyu Pharma Co Ltd 1-CARBOXY-1-VINYLOXYIMINOAMINOTHIAZOLE-CEPHALOSPORINE DERIVATIVES AND THE PRODUCTION THEREOF.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576625A (en) * 1976-04-12 1980-10-08 Fujisawa Pharmaceutical Co Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof

Also Published As

Publication number Publication date
JPS54154788A (en) 1979-12-06
ZA792584B (en) 1980-07-30
FR2426693B1 (en) 1983-02-04
IT1116196B (en) 1986-02-10
DE2921288A1 (en) 1979-12-06
BE876542A (en) 1979-11-26
GB1604722A (en) 1981-12-16
IT7949177A0 (en) 1979-05-25
BE876541A (en) 1979-11-26
NL7904127A (en) 1979-11-28
JPS54154789A (en) 1979-12-06
CH646704A5 (en) 1984-12-14

Similar Documents

Publication Publication Date Title
FR2445835A1 (en) NOVEL CEPHALOSPORINS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2433515A1 (en) PYRROLIDINECARBOXYLIC ACIDS-2 USEFUL AS ANTIHYPERTENSORS
FR2421874A1 (en) CARBOXYALKYLACYLAMINO ACIDS USEFUL AS HYPOTENSING AGENTS
FR2369297A1 (en) NEW ESTERS OF ANDROSTADIENE-17-CARBOXYLIC ACIDS
ES8502445A1 (en) Process for the preparation of cephalosporins.
FR2414508A1 (en) CEPHALOSPORINS PRODUCTION PROCESS
FR2419925A1 (en) PROCESS FOR THE MANUFACTURE OF ISOMERS-CIS OF ALKYLCYCLOHEXANOL
FR2433514A1 (en) FLUORINATED COMPOUNDS HAVING THE STRUCTURE OF VITAMIN D
FR2446287A1 (en) NEW POLYFUNCTIONAL DISULFIDE COMPOUND
ES8302098A1 (en) Process for the preparation of deacetylcephalosporin C.
FR2361406A1 (en) CEPHALOSPORIN ESTERS
BE884385A (en) PRODUCTION OF CEPHALOSPORIN BY FERMENTATION
FR2361897A1 (en) NEW CEPHALOSPORIN DERIVATIVES, THEIR INTERMEDIARIES AND PROCESS FOR PREPARING THEM
FR2375239A1 (en) 7-AMINO-8-OXO-3-OXA-1-AZABICYCLO- (4.2.0) OCTANE-2-CARBOXYLIC ACID DERIVATIVES
FR2373546A1 (en) THIO-OXIME DERIVATIVES OF CEPHALOSPORINS AND PENICILLINS, USEFUL AS B-LACTAMASES INHIBITORS
FR2355020A1 (en) B-LACTAM ANTIBIOTICS AND THEIR PREPARATION PROCESS
FR2374291A1 (en)
FR2394514A1 (en) NEW CYCLOHEXANECARBOXYLIC ACID AND ITS DERIVATIVES
FR2426693A1 (en) ANTIBIOTIC OF THE CEPHALOSPORIN TYPE AND ITS PREPARATION PROCESS
FR2355848A1 (en) 7- (A- (2,3-DIHYDRO-2-OXOBENZIMIDAZOL-1-YL-CARBONYLAMINO) ARYLACETAMIDO) CEPHALOSPORINS
FR2426688A1 (en) NEW ANTIBIOTIC NEPLANOCINS
FR2361403A1 (en) 7-12- (2-IMINO-3-HYDROXY-4-THIAZOLIN-4-ML) -ACETAMIDO) ANTIBIOTICS
ES8507555A1 (en) Cephalosporin esters.
FR2355847A1 (en) NEW CEPHALOSPORINS
FR2396751A1 (en) NEW PROCESS FOR MANUFACTURING AZETIDINONES OF THE NOCARDINIC FAMILY

Legal Events

Date Code Title Description
ST Notification of lapse